- Home
- NAAS vs MTNB Comparison
NAAS vs MTNB Comparison
Compare NAAS & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- MTNB
- Stock Information
- Founded
- NAAS 2019
- MTNB 2013
- Country
- NAAS China
- MTNB United States
- Employees
- NAAS N/A
- MTNB N/A
- Industry
- NAAS Other Specialty Stores
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- NAAS Consumer Discretionary
- MTNB Health Care
- Exchange
- NAAS Nasdaq
- MTNB Nasdaq
- Market Cap
- NAAS 8.3M
- MTNB 7.9M
- IPO Year
- NAAS 2017
- MTNB N/A
- Fundamental
- Price
- NAAS $2.75
- MTNB $1.73
- Analyst Decision
- NAAS
- MTNB Hold
- Analyst Count
- NAAS 0
- MTNB 1
- Target Price
- NAAS N/A
- MTNB N/A
- AVG Volume (30 Days)
- NAAS 142.5K
- MTNB 1.4M
- Earning Date
- NAAS 09-05-2025
- MTNB 08-14-2025
- Dividend Yield
- NAAS N/A
- MTNB N/A
- EPS Growth
- NAAS N/A
- MTNB N/A
- EPS
- NAAS N/A
- MTNB N/A
- Revenue
- NAAS $27,534,354.00
- MTNB N/A
- Revenue This Year
- NAAS $378.49
- MTNB N/A
- Revenue Next Year
- NAAS N/A
- MTNB N/A
- P/E Ratio
- NAAS N/A
- MTNB N/A
- Revenue Growth
- NAAS N/A
- MTNB N/A
- 52 Week Low
- NAAS $1.96
- MTNB $0.47
- 52 Week High
- NAAS $74.40
- MTNB $4.25
- Technical
- Relative Strength Index (RSI)
- NAAS 44.36
- MTNB 51.54
- Support Level
- NAAS $3.04
- MTNB $1.64
- Resistance Level
- NAAS $3.85
- MTNB $1.90
- Average True Range (ATR)
- NAAS 0.32
- MTNB 0.20
- MACD
- NAAS -0.00
- MTNB -0.06
- Stochastic Oscillator
- NAAS 5.31
- MTNB 6.54
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.